Loading the section
The price of DaVita Inc. (DVA) on October 9, 2026 is 179.25 USD, +1.26% on the day. Over 52 weeks the stock traded between 101.00 USD and 247.49 USD; the price now sits 53% of the way up that range. Over the past year the price changed by +40.16%. The P/E ratio is 15.6, which is below the sector median (24.8). Market capitalization is 12.21 billion USD, rank 1 among 8 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: 04 November 2026 · Earnings calendar
DaVita Inc. trades on NYSE under the ticker DVA. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks DVA has traded between 101.00 $ and 247.49 $. As of 09 October 2026 the price stood 53.42 % of the way from the 52-week low to the high.
Over one year DVA shares rose 40.16 %; over six months they rose 19.46 %. Volatility over 90 days is 41.95 %. Dividends are not included: this is price change only, as of 09 October 2026.
DVA trades at a price-to-earnings ratio of 15.6, below the sector median of 24.8. Price to sales is 0.9, below the sector median of 3.9. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 177.00 | 179.96 | 177.06 | 179.25 | 369,636 |
| 08 October 2026 | 176.58 | 179.03 | 175.41 | 177.02 | 582,200 |
| 07 October 2026 | 180.61 | 182.61 | 175.76 | 176.78 | 650,300 |
| 06 October 2026 | 179.88 | 181.82 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
DaVita runs dialysis centres — a procedure without which a patient with failed kidneys does not live.
The patient comes three times a week for several hours, for years, and chooses a centre by proximity to home. The flow is predictable down to the individual, and demand depends on neither the economy nor the season — one of the most durable models in medicine.
The economics come down to who pays: the government programme covers treatment for nearly everyone but reimburses at a rate that barely covers costs, while private insurance pays several times more. The company's profit effectively arises from a small share of commercially insured patients. Risks: reimbursement changes, staffing costs and the shift to home dialysis. The company pays no dividend but buys back stock very actively.
Address:2000 16TH STREET, DENVER, CO, 80202, US
DaVita Inc. reported revenue of 13.8B $ and net income of 781M $ over the last four quarters. Net margin is 5.65 %. Revenue changed by +6.68 % year over year. Earnings per share are 10.71 $. Market capitalisation is 12.2B $.
| 8M |
| VMDViemed Healthcare, Inc. | 9.52 | +1.17 % | 2M |
| MGRXMangoceuticals, Inc. | 0.4220 | −2.31 % | 249,358 |
| BRTXBioRestorative Therapies, Inc. | 1.86 | −1.59 % | 100,407 |
| CCELCryo-Cell International, Inc. | 4.36 | +4.56 % | 56,385 |
| 178.88 |
| 180.40 |
| 374,400 |
| 05 October 2026 | 177.96 | 179.66 | 177.43 | 178.72 | 452,000 |
| 02 October 2026 | 176.35 | 180.00 | 176.27 | 178.69 | 452,000 |
| 01 October 2026 | 174.72 | 180.16 | 173.95 | 176.35 | 653,600 |
| 30 September 2026 | 176.08 | 178.36 | 174.92 | 174.92 | 533,200 |
| 29 September 2026 | 176.92 | 176.98 | 174.08 | 175.19 | 637,000 |
| 28 September 2026 | 178.71 | 182.36 | 177.51 | 178.07 | 439,400 |
| 25 September 2026 | 175.38 | 179.10 | 174.67 | 178.47 | 519,800 |
| 24 September 2026 | 183.10 | 183.78 | 174.32 | 174.67 | 812,400 |
| 23 September 2026 | 184.03 | 186.23 | 182.48 | 183.14 | 544,300 |
| 22 September 2026 | 184.01 | 185.85 | 182.94 | 183.72 | 552,500 |
| 21 September 2026 | 184.47 | 185.00 | 182.03 | 182.34 | 565,000 |
| 18 September 2026 | 183.96 | 185.85 | 181.27 | 183.86 | 2M |
| 17 September 2026 | 194.57 | 195.75 | 182.30 | 183.09 | 1M |
| 16 September 2026 | 191.43 | 195.07 | 189.99 | 193.86 | 599,300 |
| 15 September 2026 | 188.09 | 191.40 | 186.35 | 190.90 | 685,900 |
| 14 September 2026 | 185.00 | 189.95 | 184.00 | 189.32 | 702,800 |